# Iloprost Therapy in Patients With Critical Limb Ischemia

> **NCT01458041** · — · COMPLETED · sponsor: **Bayer** · enrollment: 126 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Iloprost (Ilomedin, BAYQ6256)

## Key facts

- **NCT ID:** NCT01458041
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-12
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2015-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458041, "Iloprost Therapy in Patients With Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01458041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*